Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options
Author:
Affiliation:
1. American Urological Association Education and Research, Inc., Linthicum, Maryland
2. ASTRO, Arlington, Virginia
3. Society of Urologic Oncology, Schamburg, Illinois
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Urology
Reference45 articles.
1. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer;D'Amico;JAMA,1998
2. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer;Epstein;JAMA,1994
3. Intermediate and longer-term outcomes from a prospective active-surveillance program for favorable-risk prostate cancer;Tosoian;J Clin Oncol,2015
4. Pathologic prostate cancer characteristics in patients eligible for active surveillance: a head-to-head comparison of contemporary protocols;Iremashvili;Eur Urol,2012
5. Is clinical stage T2c prostate cancer an intermediate- or high-risk disease?;Klaassen;Cancer,2015
Cited by 666 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. MRI and active surveillance: thoughts from across the pond;European Radiology;2024-09-12
2. The Association between Specimen Neuromuscular Characteristics and Urinary Incontinence after Robotic-Assisted Radical Prostatectomy;Diagnostics;2024-09-10
3. Step-by-step Peritoneal Bladder Flap Bunching (PBFB) technique: an innovative approach following lymph node dissection in robotic radical prostatectomy;INT BRAZ J UROL;2024
4. Variation in content discussed by specialty in consultations for clinically localized prostate cancer;Urologic Oncology: Seminars and Original Investigations;2024-09
5. Usefulness of Tissue Biomarkers versus Prostate-Specific Membrane Antigen-Positron Emission Tomography for Prostate Cancer Biochemical Recurrence after Radical Prostatectomy;Cancers;2024-08-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3